Lawrence A. Silverman

1.4k total citations
33 papers, 670 citations indexed

About

Lawrence A. Silverman is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Lawrence A. Silverman has authored 33 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 13 papers in Reproductive Medicine. Recurrent topics in Lawrence A. Silverman's work include Growth Hormone and Insulin-like Growth Factors (15 papers), Hypothalamic control of reproductive hormones (12 papers) and Sexual Differentiation and Disorders (7 papers). Lawrence A. Silverman is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (15 papers), Hypothalamic control of reproductive hormones (12 papers) and Sexual Differentiation and Disorders (7 papers). Lawrence A. Silverman collaborates with scholars based in United States, United Kingdom and Canada. Lawrence A. Silverman's co-authors include Stephen M. Rosenthal, E. Kirk Neely, Alan D. Rogol, Erica A. Eugster, Gad B. Kletter, Stephen F. Kemp, Thomas A. Wilson, Dana S. Hardin, Susan R. Rose and Sally Radovick and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and The Journal of Pediatrics.

In The Last Decade

Lawrence A. Silverman

32 papers receiving 656 citations

Peers

Lawrence A. Silverman

EDM

GENET

PPCH

Mercedes Uriarte United States

Nicola Bridges United Kingdom

Emily C. Walvoord United States

Marı́a Gabriela Ballerini Argentina

Antonella Di Mambro Italy

Jadranka Popović United States

Jamal Raza Pakistan

Delphine Zénaty France

Laura Audí Spain

Alba Pilotta Italy

Mercedes Uriarte United States

Lawrence A. Silverman

473 ×1.3

EDM

251 ×0.9

245 ×1.2

170 ×0.9

GENET

117 ×0.8

PPCH

Citations per year, relative to Lawrence A. Silverman Lawrence A. Silverman (= 1×) peers Mercedes Uriarte

Countries citing papers authored by Lawrence A. Silverman

Since Specialization

Citations

This map shows the geographic impact of Lawrence A. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence A. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence A. Silverman more than expected).

Fields of papers citing papers by Lawrence A. Silverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence A. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence A. Silverman. The network helps show where Lawrence A. Silverman may publish in the future.

Co-authorship network of co-authors of Lawrence A. Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence A. Silverman. A scholar is included among the top collaborators of Lawrence A. Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence A. Silverman. Lawrence A. Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sävendahl, Lars, et al.. (2025). Seven-year Safety and Efficacy of Somapacitan in Children With GH Deficiency: Final Results From REAL 3. Journal of the Endocrine Society. 10(1). bvaf189–bvaf189. 1 indexed citations

Krishna, Kanthi Bangalore & Lawrence A. Silverman. (2024). Diagnosis of Central Precocious Puberty. Endocrinology and Metabolism Clinics of North America. 53(2). 217–227. 4 indexed citations

Silverman, Lawrence A., Mitchell E. Geffner, & Matthew Benson. (2024). Long-Acting Gonadotropin-Releasing Hormone Analogues for Central Precocious Puberty, Including 45-Mg 6-Month Subcutaneous Leuprolide Acetate: Use for Treatment and Treatment Monitoring. Hormone Research in Paediatrics. 98(3). 258–265. 2 indexed citations

Silverman, Lawrence A., et al.. (2022). A review of the genetics and epigenetics of central precocious puberty. Frontiers in Endocrinology. 13. 1029137–1029137. 15 indexed citations

Popović, Jadranka, Mitchell E. Geffner, Alan D. Rogol, et al.. (2022). Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States. Frontiers in Pediatrics. 10. 968485–968485. 12 indexed citations

Deal, Cheri, Joel Steelman, Elpis Vlachopapadopoulou, et al.. (2022). Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. The Journal of Clinical Endocrinology & Metabolism. 107(7). e2717–e2728. 51 indexed citations

Ross, Judith L., Luke Bloy, Timothy P. L. Roberts, et al.. (2019). Y chromosome gene copy number and lack of autism phenotype in a male with an isodicentric Y chromosome and absent NLGN4Y expression. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 180(7). 471–482. 5 indexed citations

Counts, Debra, Lawrence A. Silverman, Natasa Rajicic, et al.. (2015). A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing. Hormone Research in Paediatrics. 84(2). 79–87. 6 indexed citations

Bullinger, Monika, Rachel Sommer, Andreas M. Pleil, et al.. (2015). Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the United States. Health and Quality of Life Outcomes. 13(1). 43–43. 23 indexed citations

10.

Silverman, Lawrence A., E. Kirk Neely, Gad B. Kletter, et al.. (2015). Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial. The Journal of Clinical Endocrinology & Metabolism. 100(6). 2354–2363. 40 indexed citations

11.

Neely, E. Kirk, Lawrence A. Silverman, Mitchell E. Geffner, et al.. (2013). Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy. International Journal of Pediatric Endocrinology. 2013(1). 20–20. 29 indexed citations

12.

Counts, Debra, Lawrence A. Silverman, Mitchell E. Geffner, et al.. (2013). A Four-Year, Open-Label, Multi-Center, Randomized, Two-Arm Study of Genotropin® in Patients with Idiopathic Short Stature: Comparison of an Individualized, Target-Driven Treatment Regimen to Standard Dosing of Genotropin® - Analysis of Two-Year Data. Hormone Research in Paediatrics. 80(4). 242–251. 6 indexed citations

13.

Silverman, Lawrence A.. (2012). Treatment of Children With Central Precocious Puberty: 3 Years of Continuous Suppression With Histrelin Subdermal Implants. Journal of Pediatric Nursing. 27(3). e9–e10. 1 indexed citations

14.

Hey‐Hadavi, Judith, Andreas M. Pleil, Larry C. Deeb, et al.. (2010). Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyads. Clinical Therapeutics. 32(12). 2036–2047. 19 indexed citations

15.

Clarke, William L., Gad B. Kletter, Peter A. Lee, et al.. (2009). Results of a Second Year of Therapy with the 12-Month Histrelin Implant for the Treatment of Central Precocious Puberty. International Journal of Pediatric Endocrinology. 2009. 1–4. 24 indexed citations

16.

Kaplowitz, Paul B., Karen O. Klein, Joséphine Z. Kasa-Vubu, et al.. (2008). (Pediatric Endocrinology Reviews (2007) 4, SUPPL. 3). 5(3). 1 indexed citations

17.

Wilson, Thomas A., Susan R. Rose, Pinchas Cohen, et al.. (2003). Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee. The Journal of Pediatrics. 143(4). 415–421. 185 indexed citations

18.

Silverman, Lawrence A. & Stephen E. Gitelman. (1996). Immunoreactive inhibin, müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors. The Journal of Pediatrics. 129(6). 918–921. 24 indexed citations

19.

Silverman, Lawrence A.. (1991). Beyond the micro/macro distinction. European Journal of Political Research. 19(4). 375–397. 1 indexed citations

20.

Silverman, Lawrence A.. (1985). The Ideological Mediation of Party-political Responses to Social Change. European Journal of Political Research. 13(1). 69–93. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact